Mauritania vs Togo: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Mauritania
1.4%
in 2024
Togo
1.4%
in 2024
Mauritania rank
20th
Togo rank
20th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Mauritania
- Togo
How they compare
Mauritania currently reports 1.4% against 1.4% in Togo, a difference of 0.0%.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Mauritania ahead.
Mauritania ranks 20th and Togo ranks 20th of 215 countries.
Mauritania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mauritania | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.8% | 1.9% | 0.9% | Mauritania |
| 2020s | 1.6% | 1.5% | 0.0% | Mauritania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Mauritania or Togo?
- Mauritania, at 1.4% against 1.4% in Togo as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Mauritania and Togo?
- 0.0%, with Mauritania ahead.
- How many years of comparable data are there for Mauritania and Togo?
- 10 years are reported by both, from 2015 to 2024.
- How do Mauritania and Togo rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Mauritania ranks 20th and Togo ranks 20th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.